Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 6
2004 5
2005 6
2006 2
2007 5
2008 4
2009 5
2010 11
2011 12
2012 8
2013 5
2014 9
2015 11
2016 7
2017 4
2018 1
2020 1
2021 4
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

98 results

Results by year

Filters applied: . Clear all
Page 1
Insulin pump treatment vs. multiple daily insulin injections in patients with poorly controlled Type 2 diabetes mellitus: a comparison of cardiovascular effects.
Tremamunno S, Tartaglione L, Telesca A, Rizzi A, Felici T, Mazzotta F, De Vita A, Rizzo E, Cambise N, Belmusto A, Pitocco D, Lanza GA. Tremamunno S, et al. Among authors: mazzotta f. Endocrine. 2024 Apr;84(1):128-135. doi: 10.1007/s12020-023-03651-w. Epub 2024 Jan 10. Endocrine. 2024. PMID: 38197988 Free PMC article. Clinical Trial.
Von Willebrand factor hyperactivity affects the outcome of lower limb revascularization in subjects with type 2 diabetes mellitus complicated by diabetic foot vasculopathy: An observational pilot study.
Pitocco D, Popolla V, Rizzi A, Lancellotti S, Tartaglione L, Sacco M, Viti L, Mazzotta FA, Iezzi R, Santoliquido A, Caputo S, Flex A, Pontecorvi A, De Cristofaro R. Pitocco D, et al. Among authors: mazzotta fa. J Diabetes Complications. 2024 Jan;38(1):108653. doi: 10.1016/j.jdiacomp.2023.108653. Epub 2023 Nov 25. J Diabetes Complications. 2024. PMID: 38039934
Artificial Intelligence in Dermatopathology: New Insights and Perspectives.
Cazzato G, Colagrande A, Cimmino A, Arezzo F, Loizzi V, Caporusso C, Marangio M, Foti C, Romita P, Lospalluti L, Mazzotta F, Cicco S, Cormio G, Lettini T, Resta L, Vacca A, Ingravallo G. Cazzato G, et al. Among authors: mazzotta f. Dermatopathology (Basel). 2021 Sep 1;8(3):418-425. doi: 10.3390/dermatopathology8030044. Dermatopathology (Basel). 2021. PMID: 34563035 Free PMC article. Review.
Therapeutic strategies for severe COVID-19: a position paper from the Italian Society of Infectious and Tropical Diseases (SIMIT).
Mussini C, Falcone M, Nozza S, Sagnelli C, Parrella R, Meschiari M, Petrosillo N, Mastroianni C, Cascio A, Iaria C, Galli M, Chirianni A, Sagnelli E, Iacobello C, Di Perri G, Mazzotta F, Carosi G, Tinelli M, Grossi P, Armignacco O, Portelli V, Andreoni M, Tavio M; Italian Society of Infectious and Tropical Diseases. Mussini C, et al. Among authors: mazzotta f. Clin Microbiol Infect. 2021 Mar;27(3):389-395. doi: 10.1016/j.cmi.2020.12.011. Epub 2021 Jan 18. Clin Microbiol Infect. 2021. PMID: 33359375 Free PMC article.
Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected adults and the relationship with virological response: a sub-study of the NEAT001/ANRS143 randomized trial.
Dickinson L, Gurjar R, Stöhr W, Bonora S, Owen A, D'Avolio A, Cursley A, Molina JM, Fäetkenheuer G, Vandekerckhove L, Di Perri G, Pozniak A, Richert L, Raffi F, Boffito M; NEAT001/ANRS143 Study Group. Dickinson L, et al. J Antimicrob Chemother. 2020 Mar 1;75(3):628-639. doi: 10.1093/jac/dkz479. J Antimicrob Chemother. 2020. PMID: 31754703 Clinical Trial.
98 results